Dr. Matthew Bacchetta and his multidisciplinary team of North American experts conducted a comprehensive consensus study on the clinical application of ex vivo lung perfusion (EVLP) using acellular perfusate. With only 15–30% of donor lungs traditionally suitable for transplantation, this research addresses a critical need to expand donor lung utilization. EVLP offers a means to…